Multiple European countriesGermany, Sweden, France, Switzerland, the United Kingdom and the Netherlands--offer dCBT-I treatment programs backed by at least one randomized controlled trial
It didnt matter what I didthere were just some things that wouldnt change
Notably, the vast majority of RGL cells that entered the cell cycle became progenitor cells expressing neurogenic factors such as Neurod1 , Neurod2 , Neurod4 , and Eomes , during their sequential progression to neuroblast stages, whereas a small proportion of cells retained gene expression features of RGL cells with low or no expression of neurogenic factors
Many people find weekly injections more convenient, as they only need to remember one dose per week, making it easier to stick with the treatment long-term